A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
for T-cell NHL (PTCL or CTCL)
Drug: KK2223
7 locations incl. Orange
Sponsor: Kyowa Kirin, Inc.
Sex: All·Age: 18+
Code: NCT07192471·Phase 1·Not Yet Recruiting